New classification approach for inflammatory bowel disease

New classification approach for inflammatory bowel disease

This article was originally published by CORDIS and can be accessed here.

Inflammatory bowel disease (IBD) is a chronic inflammation of the gut affecting approximately 5 in 100 000 people in Europe alone. The disease is incurable with only palliative life-long treatment, emphasising the need for therapeutic interventions.

NF-kB signalling is an important cellular pathway implicated in inflammation read more